NorthWest Biotherapeutics Inc (NWBO)

[longfellow95]

Ososilver.

This describes a large international observational study of Ivermectin. OK. So not an RCT, but a good study with very well matched controls.

And a huge survival advantage for those on Ivermectin.
P = <0.001.

It obviously works. It's safe. It's cheap.
And it has a 40yr approval history.


Less resourced countries are clearly already adopting it for Covid.
But it's another drug that the US, the UK, and much of Europe will find excuse after excuse not to use.

Thanks for bringing it to my attention.